Publications by authors named "Marco Gerlinger"

Claim this Profile
P
Phenotypic heterogeneity and plasticity in colorectal cancer metastasis.
Samuel Ogden, Nasrine Metic, Ozen Leylek, Elise A Smith, Alison M Berner, Marco Gerlinger

Cell Genom· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer evolution: from Darwin to the Extended Evolutionary Synthesis.
Thomas Savy, Lucy Flanders, Thaneswari Karpanasamy, Min Sun, Marco Gerlinger

Trends Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UK cancer vaccine advance - Recognising and realising opportunities.
Charles Craddock, Philip Earwaker, Matthew Fittall, Elisa Fontana, Divya Ganesh, Marco Gerlinger

Camb Prism Precis Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and experimental treatment of advanced melanoma with a focus on immunotherapy.
Lucy Millar, Rafael Di Marco Barros, Matthaios Kapiris, Christos Nikolaou, Marco Gerlinger

Clin Exp Immunol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance Management for Cancer: Lessons from Farmers.
Sareh Seyedi, Valerie K Harris, Stefania E Kapsetaki, Shrinath Narayanan, Daniel Saha, Marco Gerlinger

Cancer Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STELLAR-303: randomized phase III study of zanzalintinib + atezolizumab in previously treated metastatic colorectal cancer.
Anwaar Saeed, Josep Tabernero, Aparna Parikh, Marc Van den Eynde, Meinolf Karthaus, Marco Gerlinger

Future Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
State of the art: Targeting microsatellite instability in gastrointestinal cancers.
Justin Mencel, Anneke Alves, Vasileios Angelis, Marco Gerlinger, Naureen Starling

Crit Rev Oncol Hematol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the toxicity of bispecific antibodies.
Marta Buzzetti, Marco Gerlinger

Nat Biomed Eng· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic and immune landscape evolution in MMR-deficient colorectal cancer.
Benjamin R Challoner, Andrew Woolston, David Lau, Marta Buzzetti, Caroline Fong, Marco Gerlinger

J Pathol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multifactorial Remodeling of the Cancer Immunopeptidome by IFNγ.
Alice Newey, Lu Yu, Louise J Barber, Jyoti S Choudhary, Michal Bassani-Sternberg, Marco Gerlinger

Cancer Res Commun· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathobionts in the tumour microbiota predict survival following resection for colorectal cancer.
James L Alexander, Joram M Posma, Alasdair Scott, Liam Poynter, Sam E Mason, Marco Gerlinger

Microbiome· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomics uncover EPHA2 as a potential novel therapeutic target in colorectal cancer cell lines with acquired cetuximab resistance.
Lucien Torlot, Anna Jarzab, Johanna Albert, Ágnes Pók-Udvari, Arndt Stahler, Marco Gerlinger

J Cancer Res Clin Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in immunotherapy for MMR proficient colorectal cancer.
Hazel Lote, Naureen Starling, Rille Pihlak, Marco Gerlinger

Cancer Treat Rev· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapy.
Florian A Büttner, Stefan Winter, Viktoria Stühler, Steffen Rausch, Jörg Hennenlotter, Marco Gerlinger

Genome Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Activity of Mitogen-Activated Protein Kinase-Targeted Therapies in Patients With Non-V600 BRAF-Mutant Tumors.
Matthew Dankner, Yifan Wang, Rouhi Fazelzad, Benny Johnson, Caroline A Nebhan, Marco Gerlinger

JCO Precis Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Questions to guide cancer evolution as a framework for furthering progress in cancer research and sustainable patient outcomes.
Jason A Somarelli, James DeGregori, Marco Gerlinger, Henry H Heng, Andriy Marusyk

Med Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of perioperative FLOT versus ECF/ECX on short-term outcomes after surgery for resectable oesophagogastric adenocarcinoma: propensity score-matched study.
Osama Moussa, Ricky Harminder Bhogal, George Malietzis, Charlotte Fribbens, Naureen Starling, Marco Gerlinger

BJS Open· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutational signatures impact the evolution of anti-EGFR antibody resistance in colorectal cancer.
Andrew Woolston, Louise J Barber, Beatrice Griffiths, Oriol Pich, Nuria Lopez-Bigas, Marco Gerlinger

Nat Ecol Evol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying key questions in the ecology and evolution of cancer.
Antoine M Dujon, Athena Aktipis, Catherine Alix-Panabières, Sarah R Amend, Amy M Boddy, Marco Gerlinger

Evol Appl· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computational Image Analysis of T-Cell Infiltrates in Resectable Gastric Cancer: Association with Survival and Molecular Subtypes.
Benjamin R Challoner, Katharina von Loga, Andrew Woolston, Beatrice Griffiths, Nanna Sivamanoharan, Marco Gerlinger

J Natl Cancer Inst· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy Sensitivity of Mismatch Repair-Deficient Cancer: Mutation Load Is Not Enough.
Marco Gerlinger

Cancer Cell· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of a coaxial versus non-coaxial liver biopsy technique in an oncological setting: diagnostic yield, complications and seeding risk.
Nicos Fotiadis, Katja N De Paepe, Lawrence Bonne, Nasir Khan, Angela Riddell, Marco Gerlinger

Eur Radiol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Tumour DNA Sequencing Identifies a Genetic Resistance-Gap in Colorectal Cancers with Acquired Resistance to EGFR-Antibodies and Chemotherapy.
Franciele H Knebel, Louise J Barber, Alice Newey, Dimitrios Kleftogiannis, Andrew Woolston, Marco Gerlinger

Cancers (Basel)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining the true impact of coronavirus disease 2019 in the at-risk population of patients with cancer.
Vasileios Angelis, Zayd Tippu, Kroopa Joshi, Sara Reis, Firza Gronthoud, Marco Gerlinger

Eur J Cancer· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic Accuracy and Safety of Coaxial System in Oncology Patients Treated in a Specialist Cancer Center With Prospective Validation Within Clinical Trial Data.
Khurum Khan, Reyes Gonzalez-Exposito, David Cunningham, Dow-Mu Koh, Andrew Woolston, Marco Gerlinger

Front Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis